If you enjoy this content, please share it with a colleague
Dilon Technologies
RELATED CONTENT
October 8, 2009 — Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique with comparable sensitivity to breast magnetic resonance imaging (MRI) for detecting breast carcinoma when used in pre-surgical planning for patients with known cancer diagnoses and is substantially less expensive than MRI, according to findings presented today at the American Society of Clinical Oncolog
June 16, 2009 – Dilon Technologies Inc. today announced the release of a new Dilon 6800 Software update, including enhancements for both breast and general nuclear medicine applications image processing.
April 27, 2009 - An additional breast cancer was found in 9 percent of patients when breast-specific gamma imaging (BSGI) was used to complement mammography, according to a study from Beth Israel Medical Center, New York, presented at the American Society of Breast Surgeons 2009 Annual Meeting in San Diego.
March 18, 2009 - Women who require additional diagnostic imaging after a questionable mammogram may be at risk for unnecessary biopsies when only MRI is offered, according to a new study presented this week at NCBC 2009.
It is not uncommon for a woman to go in for a mammogram and leave with inconclusive results. This event is usually followed by a breast ultrasound scan, and if that exam renders more inconclusive results, the doctor may recommend a breast MRI.
March 3, 2009 - Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the diagnosis of invasive lobular carcinoma (ILC), a type of breast cancer that begins in the milk-producing glands (lobules) and then spreads to the surrounding breast tissues, according to a study published in the February 2009 issue of “American Journal of Roentgenology.”
March 2, 2009 - Women facing a recent breast cancer diagnosis may find additional cancer in the same or opposite breast with further testing using Breast-Specific Gamma Imaging (BSGI) according to a study published in the February 2009 "American Journal of Surgery."
February 10, 2009 - Dilon Technologies Inc. said today it had record sales for 2008 highlighted by the strongest fourth quarter in the company's history, achieving a 35 percent increase in sales from 2007 to 2008 as molecular breast imaging gains nationwide exposure and acceptance.
February 4, 2009 - Dilon Technologies released of two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator, which are attachment options for the Dilon 6800 Gamma Camera that help to optimize imaging for the respective applications.
February 3, 2009 - Dilon Technologies Inc. today released two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator.
Both collimators are attachment options for the Dilon 6800 Gamma Camera that help to optimize imaging for the respective applications.